Inventor · disambiguated record
Ying Zhang
Also filed as: ZHANG YING · Zhang ying-yi
62 granted patents·65 pending applications·568 citations·filing 1992–2025
98Inventor score
Files withPLEXXIKON INC19UNIV JOHNS HOPKINS10RADIUS HEALTH INC9UNIV WUHAN73M INNOVATIVE PROPERTIES CO6
Top patents by PatentIndex Score
127 records- 0197US8673928B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Mar 18, 2014·60 cites·15 claims
- 0296US9617267B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Apr 11, 2017·38 cites·6 claims
- 0396US9402888B2Methods and compositions for treating cancerWISTAR INST·Filed 2014·Granted Aug 2, 2016·29 cites·9 claims
- 0495US10568937B2Formulations of abaloparatide, transdermal patches thereof, and uses thereofRADIUS HEALTH INC·Filed 2017·Granted Feb 25, 2020·17 cites·7 claims
- 0595US10154957B2Microneedle device having a peptide therapeutic agent and an amino acid and methods of making and using the same3M INNOVATIVE PROPERTIES CO·Filed 2017·Granted Dec 18, 2018·11 cites·19 claims
- 0695US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 0795US9682981B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Jun 20, 2017·25 cites·14 claims
- 0895US9624213B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA·Filed 2012·Granted Apr 18, 2017·38 cites·4 claims
- 0995US8901118B2Compounds and methods for kinase modulation, and indications thereforZHANG JIAZHONG·Filed 2011·Granted Dec 2, 2014·53 cites·46 claims
- 1094US10980862B2Formulations of abaloparatide, transdermal patches thereof, and uses thereofRADIUS HEALTH INC·Filed 2020·Granted Apr 20, 2021·5 cites·18 claims
- 1194US10695289B2Zinc compositions for coated microneedle arrays3M INNOVATIVE PROPERTIES CO·Filed 2016·Granted Jun 30, 2020·11 cites·19 claims
- 1294US10160755B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 25, 2018·15 cites·14 claims
- 1393US9676748B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 13, 2017·23 cites·20 claims
- 1493US9675675B2Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same3M INNOVATIVE PROPERTIES CO·Filed 2012·Granted Jun 13, 2017·12 cites·20 claims
- 1592US9938273B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Apr 10, 2018·17 cites·43 claims
- 1692US9623087B2Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same3M INNOVATIVE PROPERTIES CO·Filed 2012·Granted Apr 18, 2017·18 cites·18 claims
- 1788US10428067B2Compounds and methods for kinase modulationPLEXXIKON INC·Filed 2018·Granted Oct 1, 2019·8 cites·18 claims
- 1888US10301280B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 28, 2019·6 cites·21 claims
- 1987USD875953SMedical dressing3M INNOVATIVE PROPERTIES CO·Filed 2018·Granted Feb 18, 2020·26 cites·1 claims
- 2087US10543284B2Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·6 cites·36 claims
- 2187US10160747B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 25, 2018·8 cites·25 claims
- 2285US11382886B2Methods and compositions for treating cancerWISTAR INST·Filed 2017·Granted Jul 12, 2022·2 cites·18 claims
- 2385US10508085B2Compounds and methods for IDO and TDO modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 17, 2019·6 cites·37 claims
- 2485US2025195516A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2024·Application pending·0 cites
- 2584US10227357B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Mar 12, 2019·7 cites·7 claims
- 2684US6664096B2Methods for improved diagnosis and treatment of mycobacterial infectionsFiled 2001·Granted Dec 16, 2003·11 cites·57 claims
- 2783US12076322B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
- 2880US11149011B2Compounds and methods for IDO and TDO modulation, and indications thereforPLEXXIKON INC·Filed 2019·Granted Oct 19, 2021·2 cites·23 claims
- 2980US9617601B2Materials and methods for diagnosis, prognosis and assessment of therapeutic/prophylactic treatment of prostate cancerABBOTT MOLECULAR INC·Filed 2012·Granted Apr 11, 2017·3 cites·9 claims
- 3077US11337976B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 24, 2022·1 cites·10 claims
- 3177US9744224B2Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigensWISTAR INST·Filed 2016·Granted Aug 29, 2017·1 cites·12 claims
- 3277US2024174659A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2023·Application pending·0 cites
- 3373US2023277444A1FORMULATIONS OF PTHrP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOFRADIUS HEALTH INC·Filed 2022·Application pending·0 cites
- 3472US11446287B2Compounds and methods for EP300 or CBP modulation and indications thereforOPNA IMMUNO ONCOLOGY SA·Filed 2020·Granted Sep 20, 2022·1 cites·37 claims
- 3570US10604812B2Materials and methods for assessing progression of prostate cancerABBOTT MOLECULAR INC·Filed 2018·Granted Mar 31, 2020·0 cites·6 claims
- 3670US2024158810A1Compositions and methods for ameliorating anterodorsal thalamus hyperexcitabilityBROAD INST INC·Filed 2023·Application pending·0 cites
- 3770US2021052705A1METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDESRADIUS HEALTH INC·Filed 2020·Application pending·0 cites
- 3869US10548973B2Polypeptide carrier for presenting target polypeptide and uses thereofUNIV XIAMEN·Filed 2016·Granted Feb 4, 2020·1 cites·15 claims
- 3968US10081616B2Soluble epoxide hydrolase inhibitors and uses thereofX CHEM INC·Filed 2015·Granted Sep 25, 2018·1 cites·14 claims
- 4068US2024190932A1Ssx polypeptide and use thereof in treatment of synovial sarcomaTHE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV·Filed 2023·Application pending·0 cites
- 4168US2024238420A1Compositions and methods for treating acute myeloid leukemiaUNIV WUHAN·Filed 2024·Application pending·0 cites
- 4266US2021369816A1Formulations of abaloparatide, transdermal patches thereof, and uses thereofRADIUS HEALTH INC·Filed 2021·Application pending·0 cites
- 4366US2025354177A1System and methods for duplicating target fragmentsUNIV WUHAN·Filed 2023·Application pending·0 cites
- 4466US2010150844A1Use of 8-quinolinol and its analogs to target cancer stem cellsUNIV JOHNS HOPKINS·Filed 2007·Application pending·0 cites
- 4565US2020199687A1Materials and methods for assessing progression of prostate cancerABBOTT MOLECULAR INC·Filed 2020·Application pending·0 cites
- 4665US2025051803A1Dna polymerase-mediated genome editingUNIV WUHAN·Filed 2022·Application pending·0 cites
- 4764US11534398B2Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseasesCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Dec 27, 2022·0 cites·10 claims
- 4864US8741588B2Monoclonal antibodies against PBP2A derived from MRSA and methods of useHUANG RUO-PAN·Filed 2012·Granted Jun 3, 2014·1 cites·6 claims
- 4964US2023201348A1Nitric oxide hydrogel for promoting tumor vascular normalization and radiosensitization and preparation method thereofUNIV NANKAI·Filed 2022·Application pending·0 cites
- 5064US2019290738A1METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDESRADIUS HEALTH INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 127 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →